Titan Biotech

Titan_Biotech29 Apr 2024

Pharmaceuticals

₹

+9.10 (+1.79%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Titan Biotech

Titan Biotech

Pharmaceuticals

Titan_Biotech29 Apr 2024

₹

+9.10 (+1.79%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
29-May-2023	D	Audited Financial Results for Quarter and Financial Year ended 31st March, 2023 Further, the Board of Directors have recommended a dividend of Rs. 1.80/- (One Rupees Eighty Paisa Only) per equity share for the Financial Year ended on 31st March, 2023. As informed by the Company on May 29, 2023, Board of Directors has recommended a final dividend of Rs. 1.80/- per shares. The Record Date for the purpose of Final Dividend for FY 2022-2023 will be Friday, September 22, 2023. Fixing of Record Date for Dividend purpose and Scheduling of AGM (As per BSE Announcement Dated on 01/09/2023)	22-Sep-2023
30-May-2022	D	The Board recommends final dividend of Rs. 1.50 per equity shares for the financial year ended 31st March 2022, subject to approval of shareholders in AGM. Record date for Final Dividend - FY 2021-2022 subject to shareholder approval (As Per BSE Announcement Dated on 26.08.2022)	22-Sep-2022
29-Jun-2021	D	Board of Directors recommended dividend of Rs. 1.50 per equity share subject to approval of shareholders in General Meeting for financial year ended 31st March, 2021 to be scheduled later. Dates of book closure and AGM will be announced later.	16-Sep-2021
30-Jun-2020	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2020, inter alia, has recommended a dividend of Rs. 1.00 per equity for the Financial Year ended on March 31, 2020. The said dividend, if declared at the ensuing Annual General Meeting, will be credited/dispatched to the eligible shareholders after the AGM within the limit as prescribed under the Companies Act, 2013 and other applicable laws.	17-Sep-2020
29-May-2018	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2018, inter alia, have recommended a dividend of Rs. 0.75 per equity for the Financial Year ended on March 31, 2018. The said dividend, if declared at the ensuing Annual General Meeting, will be credited/dispatched to the eligible shareholders after the AGM within the limit as prescribed under the Companies Act, 2013 and other applicable laws.	19-Sep-2018
30-May-2017	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2017, inter alia, have recommended dividend of Rs. 0.75 per equity share subject to approval of shareholders in General Meeting.	21-Sep-2017
30-May-2016	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 30, 2016, inter alia, has recommended Dividend of Rs. 0.75 paise per share.	22-Sep-2016
28-May-2015	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 28, 2015, inter alia, has recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each subject to the approval of the Shareholders in the forth coming Annual General Meeting of the Company.	22-Sep-2015
04-Jun-2014	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2014, inter alia, has considered and recommended dividend of Rs. 0.75 per equity share of Rs. 10/- each subject to the approval of the Shareholders in the forth coming Annual General Meeting of the Company.	18-Sep-2014
05-Sep-2013	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 05, 2013, has recommended a final dividend of 7.5% per equity share.	19-Sep-2013
05-Sep-2011	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 03, 2011, has recommended a final dividend of 7.5% per equity share of Rs. 10 each.	22-Sep-2011
13-Sep-2010	D	Titan Biotech Ltd has informed BSE that the Board of Directors of the Company at its meeting held on September 06, 2010, inter alia, have recommended dividend of 5% on equity shares i.e. Rs. 0.50 per share for the year 2009-10 to the shareholders of the Company subject to declaration of dividend by shareholders in the AGM scheduled on September 30, 2010.	23-Sep-2010
25-Apr-2024	BC	Appointment of Secretarial Auditor and Scrutinizer of the Company	25-Apr-2024
31-Jan-2024	BC	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve unaudited financial results for quarter ende	12-Feb-2024
26-Oct-2023	BC	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Unaudited Quarterly Financial Results for Qu	08-Nov-2023
29-Sep-2023	BC	Proceeding of 31st AGM of Company. Appointment of Mr. Shivom Singla as Whole Time Director w.e.f 01 Oct 2023 , Appointment of Mr. Udit Singla as Whole Time Director w.e.f 01 Oct 2023, Appointment	01-Oct-2023
01-Sep-2023	BC	31st Annual General Meeting of Shareholders scheduled on 29th September, 2023 as per Notice of AGM being circulated shortly. Book Closure for AGM and Dividend 23.09.2023 (Saturday) to 29-09-2023 (	29-Sep-2023

Announcement Date29-May-2023

Ex Dividend Date22-Sep-2023

Dividend(%)18

Announcement Date30-May-2022

Ex Dividend Date22-Sep-2022

Dividend(%)15

Announcement Date29-Jun-2021

Ex Dividend Date16-Sep-2021

Dividend(%)15

Announcement Date30-Jun-2020

Ex Dividend Date17-Sep-2020

Dividend(%)10

Announcement Date29-May-2018

Ex Dividend Date19-Sep-2018

Dividend(%)8

Announcement Date30-May-2017

Ex Dividend Date21-Sep-2017

Dividend(%)8

Announcement Date30-May-2016

Ex Dividend Date22-Sep-2016

Dividend(%)8

Announcement Date28-May-2015

Ex Dividend Date22-Sep-2015

Dividend(%)8

Announcement Date04-Jun-2014

Ex Dividend Date18-Sep-2014

Dividend(%)8

Announcement Date05-Sep-2013

Ex Dividend Date19-Sep-2013

Dividend(%)8

Announcement Date05-Sep-2011

Ex Dividend Date22-Sep-2011

Dividend(%)8

Announcement Date13-Sep-2010

Ex Dividend Date23-Sep-2010

Dividend(%)5

No Rights has been declared by Titan_Biotech

Book Closure

Record Date	Split Date	Purpose
25-Apr-2024	-	Appointment of Secretarial Auditor and Scrutinizer of the Company
12-Feb-2024	-	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve unaudited financial results for quarter ende
08-Nov-2023	-	TITAN BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve Unaudited Quarterly Financial Results for Qu
01-Oct-2023	-	Proceeding of 31st AGM of Company. Appointment of Mr. Shivom Singla as Whole Time Director w.e.f 01 Oct 2023 , Appointment of Mr. Udit Singla as Whole Time Director w.e.f 01 Oct 2023, Appointment
29-Sep-2023	-	31st Annual General Meeting of Shareholders scheduled on 29th September, 2023 as per Notice of AGM being circulated shortly. Book Closure for AGM and Dividend 23.09.2023 (Saturday) to 29-09-2023 (

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Titan Biotech Ltd ₹518.15(+9.10/1.79%)	518.15	+9.10	420.66	115.47	17.92	3.62
Astrazeneca Pharma India Ltd ₹5,550.00(+134.60/2.49%)	5,550.00	+134.60	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹124.45(+1.85/1.51%)	124.45	+1.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,407.55(-1.85/-0.13%)	1,407.55	-1.85	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹26,264.85(+400.00/1.55%)	26,264.85	+400.00	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹710.40(+29.55/4.34%)	710.40	+29.55	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	45.98	43.43	34.75	36.84	30.33	41.83
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	45.98	43.43	34.75	36.84	30.33	41.83
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.44	0.55	0.28	0.49	0.28	0.86
Total Income	46.42	43.98	35.03	37.33	30.61	42.69
Total Expenditure	35.38	34.71	26.86	30.00	26.19	31.35
PBIDT	11.04	9.27	8.17	7.32	4.42	11.34
Interest	0.26	0.28	0.29	0.26	0.14	0.17
PBDT	10.78	8.99	7.88	7.07	4.28	11.17
Depreciation	0.83	0.86	0.80	0.71	0.65	0.64
Tax	2.54	2.07	1.67	1.78	0.93	2.65
Deferred Tax	0.01	0.02	0.01	-0.07	0.00	-0.02
Reported Profit After Tax	7.38	6.03	5.41	4.64	2.70	7.90
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	7.38	6.03	5.41	4.64	2.70	7.90

EPS (Unit Curr.)	8.93	7.30	6.55	5.62	3.27	9.56
EPS (Adj) (Unit Curr.)	8.93	7.30	6.55	5.62	3.27	9.56
Calculated EPS (Unit Curr.)	8.93	7.30	6.55	5.62	3.27	9.56
Calculated EPS (Adj) (Unit Curr.)	8.93	7.30	6.55	5.62	3.27	9.56
Calculated EPS (Ann.) (Unit Curr.)	35.74	29.18	26.18	22.48	13.08	38.25
Calculated EPS (Adj) (Ann.) (Unit Curr.)	35.74	29.18	26.18	22.48	13.08	38.25
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.26	8.26	8.26	8.26	8.26	8.26
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.01	21.34	23.51	19.87	14.57	27.11
PBDTM(%)	23.44	20.70	22.68	19.19	14.11	26.70
PATM(%)	16.05	13.88	15.57	12.60	8.90	18.89

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	45.98	43.43	34.75	36.84	30.33	41.83
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	45.98	43.43	34.75	36.84	30.33	41.83
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.44	0.55	0.28	0.49	0.28	0.86
Total Income	46.42	43.98	35.03	37.33	30.61	42.69
Total Expenditure	35.38	34.71	26.86	30.00	26.19	31.35
PBIDT	11.04	9.27	8.17	7.32	4.42	11.34
Interest	0.26	0.28	0.29	0.26	0.14	0.17
PBDT	10.78	8.99	7.88	7.07	4.28	11.17
Depreciation	0.83	0.86	0.80	0.71	0.65	0.64
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.54	2.07	1.68	1.77	0.93	2.67
Deferred Tax	0.01	0.02	0.00	-0.05	0.00	-0.04
Reported Profit After Tax	7.38	6.03	5.41	4.64	2.70	7.90
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	7.17	6.52	6.16	4.95	3.26	9.13

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	7.17	6.52	6.16	4.95	3.26	9.13

EPS (Unit Curr.)	8.68	7.89	7.47	6.07	3.95	11.04
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	8.26	8.26	8.26	8.26	8.26	8.26

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	24.01	21.34	23.51	19.87	14.57	27.11
PBDTM(%)	23.44	20.70	22.68	19.19	14.11	26.70
PATM(%)	16.05	13.88	15.57	12.60	8.90	18.89

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	8.26	8.26	8.26	8.26	8.26	7.74
Reserves Total	97.83	77.98	57.56	29.55	23.40	16.54
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	106.09	86.24	65.82	37.81	31.66	24.28
Secured Loans	8.17	9.26	8.61	11.00	3.22	4.02
Unsecured Loans	0.34	-0.33	1.65	6.86	18.44	21.34
Total Debt	8.51	8.93	10.26	17.86	21.66	25.36
Total Liabilities	114.60	95.17	76.08	55.67	53.32	49.64
APPLICATION OF FUNDS :
Gross Block	52.46	48.97	38.69	34.79	33.71	18.93
Less : Accumulated Depreciation	16.57	13.98	11.65	9.55	7.80	8.01
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	35.89	34.99	27.04	25.24	25.91	10.92
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	13.29	3.63	0.27	0.00	0.00	13.28
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	11.59	4.03	1.27	1.27	1.27	1.27
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	36.17	34.68	26.83	24.14	19.96	17.19
Sundry Debtors	21.01	16.36	16.12	10.54	7.84	8.04
Cash and Bank	4.86	6.81	5.31	1.73	1.75	1.19
Loans and Advances	6.27	5.90	1.38	1.70	2.53	2.51
Total Current Assets	68.31	63.75	49.63	38.10	32.07	28.93
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.91	9.61	7.25	6.69	4.44	2.95
Provisions	0.36	0.60	0.25	0.39	0.08	0.00
Total Current Liabilities	13.27	10.21	7.50	7.08	4.52	2.95
Net Current Assets	55.04	53.54	42.13	31.02	27.56	25.98
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.87	0.73	0.58	0.47	0.37	0.26
Deferred Tax Liability	2.08	2.00	1.93	1.66	1.39	0.99
Net Deferred Tax	-1.21	-1.27	-1.35	-1.19	-1.02	-0.73
Total Assets	114.61	94.92	69.36	56.34	53.71	50.72
Contingent Liabilities	1.13	1.62	0.77	0.77	0.00	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	8.26	8.26	8.26	8.26	8.26	7.74
Reserves Total	101.65	77.98	60.49	30.93	23.91	16.62
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	109.91	86.24	68.75	39.19	32.17	24.36
Minority Interest	0.00	0.00	3.72	2.35	1.58	1.19
Secured Loans	8.17	9.26	11.72	13.94	3.22	3.98
Unsecured Loans	0.34	-0.33	4.27	9.94	20.43	21.80
Total Debt	8.51	8.93	15.99	23.88	23.65	25.78
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	1.62	1.43	1.32	1.28	0.98	1.62
Total Liabilities	120.04	96.60	89.78	66.70	58.38	52.95
APPLICATION OF FUNDS :
Gross Block	52.46	48.97	45.51	40.85	36.90	21.74
Less: Accumulated Depreciation	16.57	13.98	11.90	9.69	7.89	8.06
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	35.89	34.99	33.61	31.16	29.01	13.68
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	13.29	3.63	0.27	0.07	0.00	13.31
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	15.41	4.03	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	36.17	34.68	32.54	27.98	21.13	17.58
Sundry Debtors	21.01	16.36	18.10	11.86	9.24	7.77
Cash and Bank	4.86	6.81	5.45	1.86	2.04	1.24
Loans and Advances	6.26	5.90	2.74	2.51	2.72	2.67
Total Current Assets	68.31	63.76	58.83	44.20	35.14	29.27
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	12.91	9.61	9.03	7.72	5.12	3.11
Provisions	0.36	0.60	0.53	0.39	0.18	0.00
Total Current Liabilities	13.27	10.21	9.55	8.11	5.30	3.11
Net Current Assets	55.04	53.55	49.28	36.10	29.84	26.16
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.60	0.48	0.38	0.26
Deferred Tax Liability	1.21	1.28	1.99	1.72	1.43	1.02
Net Deferred Tax	-1.21	-1.28	-1.39	-1.24	-1.05	-0.76
Other Assets	1.62	1.69	8.01	0.61	0.58	0.55
Total Assets
Contingent Liabilities	1.13	1.62	0.77	0.77	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	6.81	5.31	1.70	1.59	0.68
Net Cash from Operating Activities	21.18	22.04	17.59	6.92	6.20
Net Cash Used In Investing Activities	-20.73	-16.44	-4.17	-0.94	-3.74
Net Cash Used In Financing Activities	-2.40	-4.10	-9.81	-5.87	-1.55
Net Inc./Dec In Cash And Cash Equivalents	-1.95	1.51	3.61	0.11	0.90
Cash And Cash Equivalents At End Of The Year	4.86	6.81	5.31	1.70	1.59

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

55.88%

FII Shareholding

0.00%

DII Shareholding

0.23%

Public Shareholding

43.90%

**Promoter pledged shareholding 55.88%

About Titan Biotech Ltd

Titan Biotech Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 420.66 crores. It has reported a sales of Rs. 45.98 crores and a net profit of Rs. 7.38 crores for the quarter ended December 2018. The company management includes Rohit Jain, Naresh Kumar Singla,Suresh Chand Singla,Manju Singla,Charanjit Singh,Supriya Singla,Rekha Dalmia,Rohit Jain,Abhishek Agarwal,Raja Singla (Titan Biotech Ltd) among others.

Chairman

Rohit Jain

Registered office

A-902 A RIICO Industrial Area,Phase III Alwar District,Bhiwadi,Rajasthan,301019

FAX :91-011-47619811

Background

Incorporation Year1992

Face Value₹10

Market Lot1

How to buy Titan Biotech shares on nse?

To buy Titan Biotech shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Titan Biotech share price today?

The Titan Biotech shares price on nse is Rs.518.15 today.

What is the market cap of Titan Biotech shares on BSE ?

The company has a market capitalization of Rs.420.66Cr

What is the PE & PB ratio of Titan Biotech shares ?

PE is 17.92 and PB is 3.62

What is the 52 Week High and Low of Titan Biotech shares?

Titan Biotech stock price high: Rs.618 Titan Biotech stock price low: Rs.228.05